1-4 ChangeControl

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 62

Change Control

Luisa Stoppa

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, the Peoples Republic of China 16-20 November 2009

Objectives of the presentation


To answer to the following questions:
What is the purpose of change control? What must be taken into consideration when introducing change control programs? How can changes be graded? What should be regulated in a change control operating instruction? What is the function of the change control committee? How shall the implementation of changes be recorded? What has an inspector to inspect and to check?

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 2 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Programme
To introduce the general elements on change control
To train you in the guidelines (WHO-GMP, PIC/S guidelines, EU-GMP)

To become confident with SOP, forms and records of Change Control System To develop your inspection plan on change control

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 3 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Principles of change control


Before a medicinal product can be released, we need:
the manufacture and quality control procedure should be documented in the form of instructions;

The materials to be used must be specified;


The basic conditions required for a reproducible quality, efficacy and safety must be defined (i.e. suitable rooms, qualified facilities, trained personnel, validated procedures, established specifications)
Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 4 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Principles of change control


Before the requirements can be implemented, the suitability of equipments/facilities and procedures must be proven with qualification / validation This principle is not only valid the first time a medicinal product is manufactured or the first time a facility is used or a procedure comes into effect The principle applies to the whole history of a medicinal product, a procedure or a facility and it is to be guaranteed As each requirement is stated in a document, it is clear that each change control for the requirements must also always involve a documentation control
Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 5 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Principles of change control


Each change to previously approved requirements requires a review and authorization to keep the system in its original state of proven suitability Formal change control guarantees that all changes are evaluated for their effect on product quality or validation status Change control minimizes the risk that changes can have on the quality or process characteristics Change control programs have become recognized as essential element of the pharmaceutical quality assurance system
Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 6 | Nanjing, the Peoples Republic of China, 16-20 November 2009

The task of change control

Principles of change control


In the WHO-GMP guideline glossary there is definition of the term change control

However, the GMP guideline basically contains only few notes about the handling of changes
Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 7 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Principles of change control


In the American Code of Federal Regulation CFR, the responsibility for the verification and authorization of changes is task of the quality control unit In the EU regulations, the responsibility is assigned to Quality Unit

As the change control is considered an essential element of the pharmaceutical quality assurance system, it is logical the person responsible is quality assurance (QA representative, QA head)
Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 8 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Principles of change control


Change control is not department-specific, rather the task of the whole company

The change control monitors all types of changes which can influence the process or product quality and states the measures necessary for implementing the change or decides that a change should not be implemented
Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 9 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs


Change control program is a managerial task
We expect a quality structure of change control

QM statement standard operating procedure / instructions records / forms and other relevant documents

change policy operating instruction for change control change requests and other relevant documents

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 10 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs


Many types of changes affect several areas at the same time:
GMP requirements Process security (validation) Product quality (specifications, approval) Regulatory requirements

Effectiveness / safety (approval)

Suitable rooms and equipment (qualification) Suitable personnel (training, experience)

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 11 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs


A central processing of change procedures, coordinated by the quality assurance department, has several advantages:
there is a common understanding of what a change represents; the classification schemes used by the staff involved to rate changes are congruent; the risk connected with the change can be evaluated in a multidisciplinary manner; there is uniform documentation and authorization procedure

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 12 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs


The type and scope of a change control program must comply with the requirements:
1. In the classical GMP-relevant areas the change control helps to maintain the validated and established status. Validated processes, qualified facilities, material specifications can be influenced by changes and medicinal products no longer comply with specifications

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 13 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs


2. Holder of marketing authorization must guarantee that necessary regulatory pre-requisites are met. Contract manufacturers that do not have their own authorization must guarantee that the contract giver is informed of internal changes that could have an influence on their application documentation (this requires that the contract giver is included in the change control program of the contract manufacturer)

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 14 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs


3. In areas where medicinal products are developed, processes are optimized or clinical research takes place, changes should also evaluated and documented so that the development of medicinal product or process must be consistently proved

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 15 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs


Many companies rate the changes requiring control

EU-GMP
Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 16 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs


Major change Minor change Influences a unit requiring control

The example is one way to rate them:

Not requiring control No relevance to GMP or authorization No relevance to GMP or authorization

Significance of change Possible measures (selection)

Influences product quality or process reliability

Official license New approval revalidation

Amendment Review documentation

examples

Change of manufacturer: other synthesis route of a starting material (other impurities)

Replacement of apparatus part of the same design Change of cleaning agent for floors

Change to working times

Removal of processes to another site

Installation of air conditioner in administrative area

Change in the product composition

Change of laundry for work clothes (nonsterile or antibiotics area)

Change in purchase procedure

Change to the process parameters

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 17 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs


Other classifications are possible

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 18 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs


It is not decisive which and how many changeclasses a company has rated, but how it is guaranteed that changes requiring control are recognized as such and implemented according to a defined procedure

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 19 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs


Not all changes require a revalidation

WHO-GMP
Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 20 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs


In the PIC/S document PI 006 (chapter 6.7.4) there is a list of changes that may require a re-validation:

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 21 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs


Also in the WHO-GMP guidelines there is a list of changes that may require a re-validation

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 22 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs


WHO-GMP guidelines

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 23 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs


PIC/S document PI006

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 24 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs


The so called trials cause a problem in change control program. Trials are preliminary, temporary changes which can permanently established or revoked after a trial period

With trials, there is a risk that these intended temporary changes gradually become permanent changes without a formal change control procedure being carried out How long a trial is retained and whether it is withdrawn after a trial phase or be introduce permanently, should be included in the same procedure change control as all other changes

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 25 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs


Deviations should not be treated as changes, not even when deviations become changes after a failure has been clarified
Deviation is an unplanned and undesirable deviation from a requirement; it occurs spontaneously Deviations should be dealt with according a procedure about handling deviations All variations implemented in emergency (no planned, no controlled, no permanent) are included in deviations
Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 26 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs


Changes (planned changes) Deviations (unplanned changes)

Submission of request - description of change - rationale Evaluation

Notification - description of deviation Evaluation - effect on product quality - definition of corrective actions - effect on validation status - definition of revalidation measures Implementation of deviation Closing

- effect on validation status - definition of revalidation measures Approval Implementation of change Closing

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 27 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs


An important function as part of the change control program is fulfilled by the change control committee CCC (also known as change control team or change control board) This committee consists of the head of Quality assurance, the heads of manufacturing, quality control, regulatory affairs, IT department, engineering, sales
The task of the committee is to evaluate the changes, establish and coordinate measures to put in place and authorize the changes
Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 28 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs

PIC/S guideline
Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 29 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs


A problem is the issue of which changes the change control team should dealt with
It is obvious that this team cannot deal with all changes in the company As matter of fact, only changes requiring control should be processed by this team

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 30 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs


Firstly, these are changes relevant for the regulatory status
Secondly, they are changes which could have an influences on the attributes of a GMP-relevant system, facility, equipment, material/product, procedure/process The team should also deal with all changes whose grade or implementation is unclear or questionable

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 31 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs


How the team members communicate with each other?
Not all changes require a meeting In cases which are easy to make a decision about, it can be useful traditional paper-based circulation procedures, e-mail agreement or access to Intranet-based forms

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 32 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs


When a change control program has been introduced, the effectiveness of the system can be reviewed using data which is easy to determine
Total number of changes request /year
Number of completed change requests / year Change type / department involved Duration of procedure: from application to closing Number of deviations/year Number of internal or external complaints /year Number of OOS /year

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 33 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Change control programs

EU-GMP
Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 34 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Documentation
Change control requires a written procedure to establish at least the following steps:
What type of changes does change control take into account? What are the requirements for urgent changes? For which areas does this operating procedure apply? Who can suggest changes? How are changes requested (forms, method of communication)? How are changes graded and who is responsible for the rating? How are the measures for carrying out the change established? Who is responsible for the implementation and monitoring of all measures? Who is included in the change control team? What are the duties of the change control team? How is the change documented (format, content, storage)? Who is responsible to authorize changes?

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 35 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Documentation
Change control requires a written procedure to establish at least the following steps:

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 36 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Documentation
Change control requires a written procedure to establish at least the following steps:

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 37 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Documentation
All quality-relevant changes should be documented
All actions to be taken, including the need for and extent of qualification or validation, should be described

The records can be archived in paper form or electronically When storing documents, raw data and other relevant documents for change should be kept accessible

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 38 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Documentation
Changes requiring control are generally documented in the form of a change request in which the applicant for the change proposes the type of change, suggests the timeframes and measures for carrying out the change
The change control team authorizes or not the change The documentation for the change procedure should show that the change was evaluated (risk analysis)

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 39 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Documentation

WHO-GMP
Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 40 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Documentation
Change control procedure (example 1)

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 41 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Documentation
Change control procedure (example 2, 1/2)

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 42 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Documentation
Change control procedure (example 2, 2/2)

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 43 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Documentation
Change control procedure includes flow chart of the change control process and the change request form (or change form)
Change request form records a request for change so that each change is documented before it is approved The change request form includes the description of the change, the benefits, costs, urgency of the change, change impact

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 44 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Documentation
Change control procedure: flow chart (example 1)

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 45 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Documentation
Change control procedure: flow chart (example 2)
More information required

Change Request Submission Evaluation of Change Impact Validation Change Request Change Activities

Change Activities

Approval Activities Completion Change Closed Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 46 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Approval Activities Completion

Documentation
Change control procedure: flow chart (example 3)

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 47 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Documentation
Change control procedure: flow chart (example 4)

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 48 | Nanjing, the Peoples Republic of China, 16-20 November 2009

CCB = change control board

Documentation
Change control procedure: flow chart for change master documents (example 1)

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 49 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Documentation
Change request form (example 1, 1/2)

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 50 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Documentation
Change request form (example 1, 2/2)

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 51 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Documentation
Change request form (example 2, 1/2)

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 52 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Documentation
Change request form (example 2, 2/2)

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 53 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Documentation
Change request form (example 3)

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 54 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Documentation
Change database: electronic copy

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 55 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Documentation
Change control logbook
Page:__ of ____

Change control logbook (year:________)


Nb. Request date Requester / department Item Description Approval date Actions and time limit Closing date

QA Manager signature _________ Date_______


Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 56 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Examples of changes
Changes to the cleaning procedure
- use of a new cleaning agent - change in concentration / volumes of cleaning agent - change in volumes of rinsing water - change of cleaning process parameters

Changes to the production equipment


- changes to the CIP equipment - changes to / replacement of equipment parts (difficult to give detailed examples as these changes are too diverse) - change of process parameters
Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 57 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Examples of changes
Changes to the product - changes to composition (reformulation with different excipients)
- changes to the manufacturing process (i.e. transfer of a product)

Changes to HVAC system / unidirectional flow


Changes in lay-out (i.e. implementation of a pass-box)

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 58 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Inspection plan
To ask for the Change Control standard operating procedure
To check that all relevant steps for change control implementation are detailed To choose some applications (from the list in the logbook)

To verify the applications and all requested documents (change request form, investigation, request and closing date)
Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 59 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Conclusion
The old adage says: the only thing constant is change!

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 60 | Nanjing, the Peoples Republic of China, 16-20 November 2009

Reference documents
WHO GMP guidelines Technical Report series n. 937
EU GMP guidelines, Part I annex 15 ICH Q7A or EU GMP Part II chapter 13 PIC/S Recommendations PI 006-3

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors 61 | Nanjing, the Peoples Republic of China, 16-20 November 2009

[email protected]
Workshop on WHO prequalification requirements for reproductive health medicines, Jakarta, October 2009

62 |

You might also like